O for sure. That is the reason I love KTOV here. Just look at their drug. Their drug is going to be huge IMO. I think they could get some real attention for lager players soon.
"A combination drug, KIT-302, simultaneously treats pain caused by osteoarthritis and treats hypertension, which is a common side effect of stand-alone drugs that treat osteoarthritis pain. KIT-302 is comprised of two FDA approved drugs, celecoxib (Celebrex®) for the treatment of pain caused by osteoarthritis and amlodipine besylate, a drug designed to treat hypertension."
This drug had superb stage 3 results to the point where the FDA confirmed that an Advisory Committee Review should not be required for the NDA review, and that the FDA may accept 6 months data of long term stability at the time of submission.
This one is really under the radar here and has a very small float with 48% insider ownership. This stock could see a big move soon IMO.
Market Data 
Markets 
AI
